Womansiphen Tablets (Raloxifene Hydrochloride)

Adult dose

For raloxifene hydrochloride, 60 mg should be taken orally once daily.

This medication may increase the risk of blood clots in the blood. In particular, there may be a risk of clot formation in the blood vessels of the legs, lungs, and eyes, so during the use of this medication, one should be cautious of symptoms of thrombosis. Additionally, this medication is not recommended for patients with impaired liver function, and careful monitoring is required if liver function test results worsen. This medication has not been approved for use in premenopausal women; therefore, it should only be taken by postmenopausal women. It should not be used for the purpose of preventing cardiovascular diseases and should be administered cautiously to patients at risk of stroke. Women who are pregnant or may become pregnant or those who are breastfeeding should not take this medication as it may affect the fetus or baby. Patients with a history of thrombosis, liver disorders, unexplained uterine bleeding, or symptoms of endometrial cancer should also avoid this medication. Furthermore, it should not be given to patients who have been immobile for a long time or those with certain genetic lactose intolerance. Patients with high triglycerides in the blood or severely impaired kidney function should use this medication with caution. During treatment, side effects such as leg cramps, facial flushing, cold symptoms, peripheral edema may occur, and if unusual symptoms persist, consult a physician. This medication may interact with other medications, so if you are taking any other medications, be sure to inform your healthcare provider. It is advisable to take supplements if calcium and vitamin D are deficient, and it is recommended to improve smoking and drinking habits. This medication is for use in menopausal women only; it should not be administered to children or men. In case of overdose, symptoms such as leg cramps and dizziness may appear, but there is no specific antidote. When storing, keep it out of reach of children and do not transfer it to other containers for safety.

Serious side effects

• Deep vein thrombosis
• pulmonary embolism
• retinal vein thrombosis
• superficial vein thrombophlebitis
• arterial thromboembolism
• retinal vein occlusion
• stroke
• death related to deep vein thrombosis

Mild side effects

Vasodilation (facial flushing), leg cramps, cold symptoms, peripheral edema, nausea, vomiting, abdominal pain, indigestion, increased blood pressure, migraine, rash, pain, mild breast symptoms such as swelling and tenderness, vaginal bleeding, facial swelling, heartburn, constipation, itching, palpitations, fever, weakness, sweating, muscle pain, insomnia, perineal pain, weight gain, arthritis, rheumatic pain, fatigue, discomfort, chest tightness, skin lesions, anxiety, malaise

This medication should be stored in a tightly sealed container to prevent air or moisture from entering, and it is best kept in a cool place between 15 to 30 degrees Celsius. Storing it this way can help maintain its effectiveness for a long time.

Appearance

White oval film-coated tablet

Package unit

14 tablets (14 tablets PTP X 1), 28 tablets (14 tablets PTP X 2)